Ceasing to be a substantial holder
ASX Announcement General iTrack Molteno3 AlphaRET
20 Mar, 2024
Change in substantial shareholding from AEF
ASX Announcement General iTrack Molteno3 AlphaRET
20 Mar, 2024
Change of Director's Interest Notice VP
ASX Announcement General iTrack Molteno3 AlphaRET
19 Mar, 2024
Change of Director's Interest Notice VP
ASX Announcement General iTrack Molteno3 AlphaRET
19 Mar, 2024
Change of Director's Interest Notice
ASX Announcement General iTrack Molteno3 AlphaRET
19 Mar, 2024
Retail Entitlement Offer Complete
ASX Announcement General iTrack Molteno3 AlphaRET
15 Mar, 2024
Record USA Sales for February 2024
ASX Announcement General iTrack Molteno3 AlphaRET
5 Mar, 2024
Half Yearly Report and Accounts
ASX Announcement General iTrack Molteno3 AlphaRET
23 Feb, 2024
Cleansing Notice
ASX Announcement General iTrack Molteno3 AlphaRET
23 Feb, 2024
Despatch of Entitlement offer Completed
ASX Announcement General iTrack Molteno3 AlphaRET
19 Feb, 2024
Retail Entitlement Offer Booklet
ASX Announcement General iTrack Molteno3 AlphaRET
19 Feb, 2024
Appendix 3B - Proposed Issue of Securities
ASX Announcement General iTrack Molteno3 AlphaRET
14 Feb, 2024
EYE Placement & Institutional Offer Completion
ASX Announcement General iTrack Molteno3 AlphaRET
14 Feb, 2024
Investor Presentation
ASX Announcement General iTrack Molteno3 AlphaRET
12 Feb, 2024
Proposed issue of securities
ASX Announcement General iTrack Molteno3 AlphaRET
12 Feb, 2024
Cleansing Notice - Notice under section 708AA(2)(f) of the Corporations Act 2001 (Cth)
ASX Announcement General iTrack Molteno3 AlphaRET
12 Feb, 2024
Capital Raise for Expansion
ASX Announcement General iTrack Molteno3 AlphaRET
12 Feb, 2024
Trading Halt
ASX Announcement General iTrack Molteno3 AlphaRET
12 Feb, 2024
Response to ASX Aware Query
ASX Announcement General iTrack Molteno3 AlphaRET
4 Jan, 2024
USA Medicare Changes Withdrawn
ASX Announcement General iTrack Molteno3 AlphaRET
29 Dec, 2023
Deferral of Proposed USA Medicare Changes
ASX Announcement General iTrack Molteno3 AlphaRET
8 Dec, 2023
Further Update of Proposed USA Medicare Changes
ASX Announcement General iTrack Molteno3 AlphaRET
28 Nov, 2023
AGM Presentation
ASX Announcement General iTrack Molteno3 AlphaRET
23 Nov, 2023
Further Update on Proposed USA Medicare Changes
ASX Announcement General iTrack Molteno3 AlphaRET
14 Nov, 2023
Trading Halt
ASX Announcement General iTrack Molteno3 AlphaRET
10 Nov, 2023
Proposed USA Medicare Changes
ASX Announcement General iTrack Molteno3 AlphaRET
31 Oct, 2023
Trading Halt
ASX Announcement General iTrack Molteno3 AlphaRET
27 Oct, 2023
Notice of Annual General Meeting
ASX Announcement General iTrack Molteno3 AlphaRET
20 Oct, 2023
Date of AGM & Closing Date for Director Nominations
ASX Announcement General iTrack Molteno3 AlphaRET
25 Sept, 2023
INVESTOR WEBINAR PRESENTATION - SHARECAFE
ASX Announcement General iTrack Molteno3 AlphaRET
15 Sept, 2023
Evans & Partners Small Cap Healthcare Conference Presentation
ASX Announcement General iTrack Molteno3 AlphaRET
12 Sept, 2023
EYE FY2023 Appendix 4G and Governance Statement
ASX Announcement General iTrack Molteno3 AlphaRET
28 Aug, 2023
EYE FY2023 Results Announcement
ASX Announcement General iTrack Molteno3 AlphaRET
28 Aug, 2023
EYE FY2023 Results Presentation
ASX Announcement General iTrack Molteno3 AlphaRET
28 Aug, 2023
EYE FY2023 Appendix 4E and Annual Report
ASX Announcement General iTrack Molteno3 AlphaRET
28 Aug, 2023
Investor Webinar Full Year (FY23) Results
ASX Announcement General iTrack Molteno3 AlphaRET
23 Aug, 2023
TechKnow Invest Roadshow Presentation August 2023
ASX Announcement General iTrack Molteno3 AlphaRET
3 Aug, 2023
iTrack™ Advance Sales in the USA Driving Strong Results
ASX Announcement General iTrack Molteno3 AlphaRET
2 Aug, 2023
Investor Presentation - ShareCafe
ASX Announcement General iTrack Molteno3 AlphaRET
19 May, 2023
Cleansing Notice
ASX Announcement General iTrack Molteno3 AlphaRET
5 May, 2023
Application for Quotation of Securities
ASX Announcement General iTrack Molteno3 AlphaRET
5 May, 2023
iTrack Advance First Surgeries and Sales in USA
ASX Announcement General iTrack Molteno3 AlphaRET
1 May, 2023
For investor enquires please contact:
Mark Flynn
Nova Eye Medical Limited
W +61 416 068 733
mflynn@nova-eye.com
This website uses cookies to ensure you get the best experience on our website.
The cookies do not store any personalised information. Learn More
The cookies do not store any personalised information. Learn More